BioCentury
ARTICLE | Clinical News

Fluticasone propionate MDPI: Phase III data

November 23, 2015 8:00 AM UTC

Top-line data from the double-blind, international Phase III Study FSS-AS-301 in 1,363 adolescent and adult patients with persistent asthma that was symptomatic despite low- or mid-dose inhaled cortic...